At Powerful Medical, our Scientific Board stands at the forefront of our commitment to excellence in healthcare, research, and education.
Composed of a distinguished group of internationally acclaimed doctors, researchers, and healthcare professionals, our Scientific Board ensures that healthcare professionals receive the tools that are not only cutting-edge but also safe, ethical, and tailored to meet the individual needs of their patients.
A renowned interventional cardiologist known for contributions to coronary artery disease treatment, deeply involved in clinical research, focusing on optimizing percutaneous coronary interventions and advancing cardiovascular care practices.
With over 100 peer-reviewed publications in cardiovascular journals, he serves on several steering committees for international trials and participates in multiple scientific and EAPCI Programme Committees.
Dr. Perl serves as the Director of Complex Cardiac Interventions and holds the role of Chief Innovation Officer at the Rabin Medical Center in Israel.
Graduated from the renowned Stanford Biodesign Program, he has been a driving force behind multiple healthcare innovation projects pushing the boundaries of medical advancement.
Dr. Baron is the Director of Interventional Cardiology Research at the Massachusetts General Hospital in Boston.
She received her masters degree in health economics from Harvard School of Public Health and is an expert in research involving the effects of cardiovascular devices on healthcare costs and patient-reported outcomes.
Prof. Dr. Hatala is the Head of the Arrhythmia department at the esteemed National Institute of Cardiovascular Diseases in Slovakia. His contributions to medicine are evident in a substantial body of work, including more than 150 publications. Additionally, he plays an integral role as a contributor to the clinical practice guidelines of the European Society of Cardiology.
Dr. Ward Heggermont serves as the Co-director at the Cardiovascular Center of Aalst Hospital, specializing in the multifaceted domain of heart failure. Throughout his career, he has cultivated a keen interest in the intersecting scientific disciplines of Cardiology, Virology, and Metabolism. He is actively engaged in scientific research at the OLV Aalst Heart Center and CARIM, where his work primarily revolves around epigenetics and biomarker research.
Dr. Martin Penicka is an acclaimed cardiologist specialising in non-invasive imaging, valvular disease, and corfals with PhD Doctorate in Medical Sciences and certifications as a Fellow of the European Society of Cardiology (FESC) and European Association of Cardiovascular Imaging (FEACVI). He has been an integral member of Heart Center OLV Aalst since 2009.
Dr. Tom De Potter is a renowned cardiologist specialising in Pacemaker Device Therapy and Electrophysiology. With a focus on refining his expertise at Hartcentrum OLV Aalst, Belgium, Dr. De Potter made significant contributions to advancements in these fields. His unwavering dedication and patient-centred approach have established him as an influential figure in cardiology worldwide.
Prof. Dr. Hatala is the Head of the Arrhythmia department at the esteemed National Institute of Cardiovascular Diseases in Slovakia. His contributions to medicine are evident in a substantial body of work, including more than 150 publications. Additionally, he plays an integral role as a contributor to the clinical practice guidelines of the European Society of Cardiology.
Dr. Javaid is the Cardiovascular Clinical Lead at East Midlands Clinical Networks, qualified from Cambridge University. He has a specialist interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service. He was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions. He is on the editorial board for the British Journal of Cardiology.
Dr. Khan is a Consultant Cardiologist at Barts Heart Centre, specialising in heart rhythm disorders. With General Medicine and Cardiology training in Oxford, Cambridge, and Canada, he was awarded the Mirium L Burnett Fellowship in Electrophysiology and Devices. Dr. Khan’s exceptional contributions have earned him the Young Investigator Award and the prestigious Ralph Noble Prize.
We joined forces with Cardiovascular Research Center Aalst , a world-renowned authority in cardiology. The alliance blends Powerful Medical state-of-the-art technology with the globally acclaimed clinical expertise of the Heart Center Aalst, aspiring to unlock new dimensions in cardiac care and improve patient outcomes.
Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.
PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.
Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.